Skip to main content
Clinical Trials/ISRCTN18033113
ISRCTN18033113
Completed
未知

A randomized controlled trial to assess and compare the outcomes of AI-US-CT-guided biopsy, transrectal ultrasound-guided 12-core systematic biopsy, and mpMRI-assisted 12-core systematic biopsy

Science Technology Department of Zhejiang Province0 sites450 target enrollmentDecember 28, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
Prostate cancer
Sponsor
Science Technology Department of Zhejiang Province
Enrollment
450
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35852595/ (added 11/08/2022)

Registry
who.int
Start Date
December 28, 2016
End Date
December 31, 2017
Last Updated
3 years ago
Study Type
Interventional
Sex
Male

Investigators

Sponsor
Science Technology Department of Zhejiang Province

Eligibility Criteria

Inclusion Criteria

  • 2\. Under 85 years of age
  • 3\. Verified prostate\-specific antigen (PSA) \> 4 ng/ml and/or abnormal DRE
  • 4\. Provision of signed informed consent

Exclusion Criteria

  • 1\. No signed informed consent
  • 2\. Patients who have been included in published cohorts

Outcomes

Primary Outcomes

Not specified

Similar Trials